Previous studies demonstrated association of MBL plasma levels with acute COVID-19 MBL2 gene polymorphisms, where patients with polymorphic genotypes had lower levels of MBL (37, 39), but these assessments were made only in patients with severe COVID-19 forms. The gene discussed is MBL2; the disease is COVID-19.